Skip to main content
. 2009 Jan 29;24(Suppl 1):S189–S194. doi: 10.3346/jkms.2009.24.S1.S189

Fig. 2.

Fig. 2

Immunostaining for advanced glycation end products in the peritoneal vascular wall. The vessels of group I (A) and group II (B) show moderate to strong expression. However, the vessels of group III (C) show weak expression.